Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Aiming to expand its presence in Europe as well as its business in regenerative medicines, Hitachi Chemical will acquire Apceth Biopharma, a German contract manufacturer, for about $85 million. The deal follows Hitachi’s purchase of PCT, a US regenerative medicines contractor, in 2017 and the opening of a contract development and manufacturing facility in Yokohama, Japan, last April. Apceth specializes in producing cancer immunotherapy cells, induced pluripotent stem cells, and mesenchymal stem cells.
This article has been sent to the following recipient: